The present disclosure relates to devices, systems and methods for treatment of obesity.
Obesity is a major health concern in the United States and other countries. A significant portion of the population is overweight with the number increasing every year. Obesity is one of the leading causes of preventable death. Obesity is associated with several co-morbidities that affect almost every body system. Some of these co-morbidities include: hypertension, hyperglycemia, heart disease, stroke, high cholesterol, diabetes, coronary disease, breathing disorders, sleep apnea, cancer, gallstones, and musculoskeletal problems. An obese patient is also at increased risk of developing Type II diabetes.
Multiple factors contribute to obesity, including physical inactivity and overeating. A variety of medical approaches have been devised for treatment of obesity. Existing therapies include diet, exercise, appetite suppressive drugs, metabolism enhancing drugs, surgical restriction of the gastric tract, and surgical modification of the gastric tract. In general, surgery is reserved for patients in whom conservative measures, such as monitoring caloric intake or controlling appetite with appetite suppressants, have failed. In addition, surgery is generally reserved for patients who are seriously, and sometimes morbidly, overweight.
There have been many surgical approaches to obesity. For example, some patients have received implantation of one or more bulking prostheses to reduce stomach volume. A bulking prosthesis resides within the stomach and limits the amount of food the stomach can hold, theoretically causing the patient to feel a sensation of satiety. U.S. Patent Application Publication No. 20030040804 to Stack et al., for example, describes a tubular prosthesis that is designed to induce sensations of satiety within a patient.
Another approach is restrictive surgery, which surgically makes the stomach smaller by removing or closing a section of the stomach. This procedure also reduces the amount of food the stomach can hold, causing the patient to feel full. U.S. Patent Application Publication No. 20020183768 to Deem et al., discloses various techniques for reducing the size of the stomach pouch to limit caloric intake, as well as to provide an earlier feeling of satiety.
Another surgical procedure to treat obesity is the gastric bypass procedure. In the gastric bypass procedure, the surgeon creates a small stomach pouch to restrict food intake and constructs a bypass of the duodenum and other segments of the small intestine. This procedure limits the amount of food that can be ingested and subsequently digested or absorbed.
Surgical procedures for treatment of obesity, such as those described above, tend to be highly invasive, and each form of surgery may involve complications. Restrictive surgery may entail a risk of vomiting, for example, and gastric bypass surgery may result in unpleasant consequences known as “dumping syndrome.”
U.S. Pat. No. 6,540,789 to Silverman describes a technique for treatment of obesity involving introduction of an implant material into the stomach wall in the vicinity of the pyloric sphincter to inhibit emptying of the stomach. Silverman also describes introduction of an implant material to reduce distensibility and contractility of the stomach.
U.S. Patent Application Publication No. 20100331617 to Forsell describes an operable stretching device implantable in an obese patient for stretching a patient's stomach wall via an external operation device.
U.S. Patent Application Publication No. 20050245957 to Starkebaum et. al. hereby incorporated by reference in its entirety, describes devices and methods designed to bias stretch receptors in the stomach wall of a patient to treat obesity. Biasing of the stretch receptors by pre-stretching induces early sensation of satiety, causing the patient to consume less food.
U.S. Patent Application Publication No. 20060173238 to Starkebaum, hereby incorporated by reference in its entirety, describes a dynamically controlled gastric occlusion device which may control the degree of gastric constriction of an occluding device based upon a monitored physiological parameter or based upon time. By dynamically controlling the degree of gastric constriction, the device limits the ingestion of food to reduce caloric intake so that the patient loses weight while permitting ingestion of caloric energy necessary to prevent malnourishment.
In general, the present disclosure relates to abdominal stretch devices and methods for treatment of obesity of a patient. Stretching an area of the gastrointestinal (GI) tract may induce an early sensation of satiety, causing a patient to consume less food. In accordance with the disclosure, stretching of the gastrointestinal tract can be achieved by attachment of stretch devices to the wall of the stomach. Stretch devices attached to the stomach wall may trigger stretch receptors to expand the stomach wall into a state of apparent stretching, causing early onset of satiety. In this manner, the devices are capable of discouraging excessive consumption of food without the use of appetite suppressant medications or more invasive surgical intervention. In various embodiments, the stretched condition of the stomach wall may activate stretch receptors to provide, in effect, an early warning system for cessation of meal consumption. Consequently, the devices according to the disclosure may counteract increased obesity and promote weight loss among obese patients.
Some aspects in accordance with principles of the present disclosure relate to a stretch device or a plurality of stretch devices which may be attached to a wall of the stomach to stretch the stomach wall.
In some embodiments, stretch devices may be attached to the inside or outside of the stomach wall at various locations (for example at the fundus or greater curvature) on or within any of the layers of the stomach for example, the serosal, muscle or mucosal layers of the stomach; or may be placed at any other location of the GI tract (for example the small intestine or pylorus).
In yet further embodiments, stretch devices may be adjustable and may be expandable and/or contractible and may comprise actuation means. Stretch devices may comprise self-actuation or mechanical actuation means. In some embodiments, stretch devices may comprise adjustable elements and may comprise attachment assemblies for attaching the adjustable elements to tissue. Adjustable elements and/or attachment assemblies may comprise materials which self-expand following attachment to the stomach. Adjustable elements and/or attachment assemblies may comprise materials, polymers or alloys comprising any of the following materials or material properties: smart, memory, shape memory, superelastic, pseudoelastic, self-expanding, and/or self-reverting. In this manner, stretch devices may be easily and quickly implanted without the need for more complex or complicated operating systems to control the degree of stretch of the stomach tissue to which the stretch device or devices are attached. Stretch devices and/or portions of stretch devices according to further embodiments may comprise biocompatible metals, alloys or polymers. Stretch devices and/or portions of stretch devices may also comprise biodegradable, bioabsorbable or bioresorbable materials. In some embodiments, stretch devices may comprise coatings which may enhance biocompatibility and/or aid in anchoring, attachment, placement or delivery of the devices.
Stretch device members or elements may take various forms or configurations and may comprise for example, adhesives, glues, stents, wires, filaments, coils, springs, telescoping elements, hooks, clips, sutures, anchors, pledgets, rivets, barbs, struts, screws, meshes, patches and/or sheets and may further comprise a unitary component or multiple components.
Stretch devices may be attached to the stomach wall at one or more locations and may be attached in various configurations. Stretch devices may be attached to the stomach wall at linear or non-linear spaced-apart locations and may be oriented in any direction along the stomach wall. For example, stretch devices may be configured to stretch the stomach wall along the contours of the stomach wall. Stretch devices may stretch tissue of the stomach wall in one or more directions and in more one or more dimensions (e.g. two-dimensionally or three-dimensionally) and may, for example stretch the stomach wall in a radial fashion.
Stretch devices in accordance with the present disclosure may be adapted for attachment to the stomach of a patient via placement devices and may be adapted to be delivered to locations along the stomach via laparoscopic or endoscopic surgical techniques. Systems according to some embodiments of the present disclosure may comprise laparoscopic or endoscopic delivery devices sized for introduction into a stomach of a patient via laparoscopic instruments or via the esophagus of a patient. A placement, tool and/or delivery device may hold a stretch device or devices or portions of a stretch device for delivery and attachment to the wall of the patient's stomach. As examples, the placement and/or delivery tools may take the form of a gripping member that grips a stretch device, or the placement tool may take the form of a device comprising a lumen such as a catheter, a hollow needle or a tube.
Other aspects in accordance with principles of the present disclosure relate to a method of stretching a portion of a gastrointestinal tract of a patient and may comprise attaching a stretch device or devices to a stomach wall of a patient to expand the stomach wall and thereby induce a sensation of satiety in the patient.
Various embodiments of the present disclosure are capable of solving at least some of the problems mentioned above. For example, devices, systems and methods in accordance with the present disclosure may provide a treatment for obesity that presents greater efficacy and lesser side effects relative to administration of conventional appetite suppressant medications. In some embodiments, devices of the present disclosure may be capable of being delivered laparoscopically or endoscopically and may thereby avoid the need for more highly invasive surgical procedures. Devices in accordance with the disclosure may thus be capable of avoiding substantial reconstruction of the stomach, and offer reduced damage, recovery time, and side effects.
The details of one or more embodiments of the present disclosure are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the disclosure will be apparent from the description and drawings, and from the claims.
Stretch devices 10 (also 20, 30, 40) as hereinafter described with reference to
Stretch device 10 or portions of stretch device 10 may be attached to the serosa, the mucosa, the submucosa or the muscularis 26, which contains the stretch receptors. The stretch receptors are coupled to the nervous system via the vagus nerves, and signal the patient when stomach 13 reaches a stretch point indicating a large quantity of food. With stretch device 10 attached and expanded, the patient perceives that the stomach has reached a stretch point indicating fullness much earlier during the course of the meal and at a point at which the stomach is not actually full. Stretch device 10 may be attached to or may embed in only one or several or portions of the layers of the stomach wall 21. Stretch device 10, for example, may attach to the stomach wall 21 at the serosa 28 at at least two spaced apart locations. Stretching or expansion of stretch device 10 following attachment to the stomach tissue may cause the tissue or layers of the stomach tissue T between the areas of attachment of stretch device 10 to expand as adjustable member 17 and thereby device 10 expands and may thus expand stretch receptors in the stomach wall 21 and induce a sensation of satiety in a patient.
As further shown in
Adjustable member 17 (referenced generally) may be formed from a smart memory, shape memory, superelastic, pseudoelastic, self-expanding, and/or self-reverting material, alloy or polymer. Following attachment of an adjustable member 17 to a location along the stomach 13, adjustable member 17 may assume an expanded or undeformed state thereby transitioning stretch device 10 to an expanded condition. The expanded state of adjustable member 17 may be described as a memory-set or shape memory set state. In some embodiments adjustable member 17 may comprise biocompatible materials of alloys which are not shape memory materials. With this construction, following attachment of stretch device 10 to tissue, stretch device 10 may be mechanically expandable upon attachment such as via a spring-like mechanism. As described above, attachment assembly 32 may be integrally formed with adjustable member 17 and may comprise the same material as adjustable member 17. Alternatively, attachment assembly 32 may comprise materials different from adjustable member 17. Attachment assembly 32 may comprise shape memory materials as described above and may transition from a first delivery state to a second attachment state separate from the transitioning of adjustable member 17 from a contracted state to an expanded state.
Stretch device 10 may be expanded to a condition with a size sufficient to expand stretch receptors within stomach wall 21. When expanded in this way, stretch device 10 exerts a localized stretching force on stretch receptors in stomach 13. The stretch receptors are coupled to the enteric nervous system of a patient. When triggered by the stretching force, the stretch receptors induce a sensation of satiety in the patient, and discourage the patient from consuming an excessively large meal. The role of stretch receptors in human gastric function is discussed, for example, in A. S. Paintal, “A study of gastric stretch receptors; their role in the peripheral mechanism of satiation of hunger and thirst,” J. Physiol. Nov. 29, 1954; 29; 126(2):255-70.
Stretch device 10 stretches stomach wall 21 into a stretched condition that either triggers the stretch receptors or causes earlier triggering of the stretch receptors during the consumption of a meal. Hence, even though the stomach may not contain a substantial portion of food at the outset of a meal, implanted or attached stretch device 10 has already stretched the stretch receptors into a condition that simulates the presence of a substantial portion of food. Consequently, during the course of a meal, stomach 13 requires a smaller amount of food to produce a sensation of satiety, which causes the patient to stop eating.
Stretch device 10 is configured such that even in an expanded state, the device does not significantly change the overall size or contents of stomach 13, but provides a localized modification of the stomach wall 21. This modification affects the response of the patient's enteric nervous system and the amount of food consumed by the patient, thereby preventing increased obesity and possibly causing or assisting in weight loss. In some cases, stretch device 10 may be explanted after a desired course of obesity treatment has been achieved.
Stretch device 10 may be implanted or attached surgically from the serosal aspect of stomach 13 (i.e., from the outer surface) or endoscopically from the mucosal aspect of the stomach (i.e., from the inside surface) of the stomach. The esophagus 12 of the patient may be intubated with the endoscopic delivery device via the oral or nasal passage under general anesthesia. Additionally, surgical implantation may involve laparoscopic techniques. In this manner, a highly invasive surgery can be avoided, and recovery time can be shortened.
One embodiment of a stretch device (stretch device 20) is shown in
As depicted in
In the examples of
The amount of stretch the stomach undergoes after attachment and expansion of stretch device 10 may be dependent upon the patient and may for example, be an amount of stretch sufficient to create a sensation of satiety sufficient to discourage the patient from consuming an excessively large meal. In some embodiments the stretch ratio of the stomach tissue from an at least partially stretched tissue state may be at least approximately two times and more particularly may be approximately twenty times. In some embodiments the amount of stretch of tissue of the stomach may comprise an amount sufficient to create a hormonal or neuronal response thereby inducing a sensation of satiety in the patient.
Another embodiment of a stretch device (stretch device 30) is shown in
As depicted in
Another embodiment of a stretch device (stretch device 40) is shown in
Stretch devices 10, 20, 30, 40 according to the disclosure may additionally comprise electrodes at various locations for stimulation of stomach tissue. U.S. Patent Application Publication No. 20110071589 to Starkebaum et. al, incorporated by reference herein in its entirety, describes systems, devices and techniques for delivering electrical stimulation therapy to a patient.
Although the present disclosure has been described with reference to embodiments, workers skilled in the art will recognize that changes can be made in form and detail without departing from the spirit and scope of the present disclosure.
This application is related to U.S. Patent Application 61/591,316, entitled “Gastric Stretch Devices, Systems and Methods for Treatment of Obesity” filed on Jan. 27, 2012, incorporated by reference herein in its entirety.
Number | Date | Country | |
---|---|---|---|
61591316 | Jan 2012 | US |